HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Permissions Request Permissions Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (2) Citing Articles via Google Scholar Google Scholar Articles by Takeda, K. Articles by Gelfand, E. W. Search for Related Content PubMed PubMed Citation Articles by Takeda, K. Articles by Gelfand, E. W.

S-carboxymethylcysteine normalises airway responsiveness in sensitised and challenged mice

¹ Dept of Paediatrics, National Jewish Medical and Research Center, Denver, CO, USA. ² Okayama University Medical School, Okayama, Japan.

CORRESPONDENCE: E. W. Gelfand, 1400 Jackson Street, Denver, CO 80206, USA. Fax: 1 3032702105. E-mail: gelfande{at}njc.org

Keywords: Airway hyperresponsiveness, eosinophils, neutrophils, S-carboxymethylcysteine

Received: July 30, 2004
Accepted June 10, 2005

S-carboxymethylcysteine (S-CMC) has been used as a mucoregulator in respiratory diseases. However, the mechanism of action of S-CMC on allergic airway inflammation has not yet been defined.

In the present study, BALB/c mice were initially sensitised and challenged to ovalbumin (OVA) and, weeks later, re-challenged with OVA (secondary challenge). S-CMC (5–100 mg·kg^–1) was administered from 2 days before the secondary challenge through to the day of assay.

Mice developed airway hyperresponsiveness (AHR) 6 h after the secondary challenge and increased numbers of neutrophils were present in the bronchoalveolar lavage (BAL) fluid. At 72 h after secondary challenge, mice again developed AHR, but the BAL fluid contained large numbers of eosinophils. S-CMC treatment was found to reduce AHR and neutrophilia at 6 h, as well as eosinophilia and AHR at 72 h. These effects appeared to be dose dependent. Goblet cell hyperplasia, observed at 72 h, was reduced by S-CMC. In BAL fluid, increased levels of interferon-, interleukin (IL)-12 and IL-10 and decreased levels of IL-5 and IL-13 were detected.

In conclusion, the data indicate that S-carboxymethylcysteine is effective in reducing airway hyperresponsiveness and airway inflammation at two distinct phases of the response to the secondary allergen challenge in sensitised mice.

This article has been cited by other articles:

				K. Takeda, S. W. Dow, N. Miyahara, T. Kodama, T. Koya, C. Taube, A. Joetham, J.-W. Park, A. Dakhama, R. M. Kedl, et al. Vaccine-Induced CD8+ T Cell-Dependent Suppression of Airway Hyperresponsiveness and Inflammation J. Immunol., July 1, 2009; 183(1): 181 - 190. [Abstract] [Full Text] [PDF]

				M. Okamoto, K. Takeda, A. Joetham, H. Ohnishi, H. Matsuda, C. H. Swasey, B. J. Swanson, K. Yasutomo, A. Dakhama, and E. W. Gelfand Essential role of Notch signaling in effector memory CD8+ T cell-mediated airway hyperresponsiveness and inflammation J. Exp. Med., May 12, 2008; 205(5): 1087 - 1097. [Abstract] [Full Text] [PDF]